bioRxiv Science⌕ Search

Biology subjects

Hatfield, S.

Publications and source records attributed to Hatfield, S..

2 recordsLinked to original sources

Structure-Led Exploration of the Metagenome Yields Novel RNA-Guided Nucleases with Broad PAM Diversity

Compact RNA-guided nucleases with favorable targeting properties are challenging to discover due to their low natural abundance. Here, we develop a structure-led search strategy -leveraging predicted protein folds and sequence-independent similarity metrics -to systematically identify extremely low-homology compact RNA-guided nucleases across vast metagenomic datasets with high computational efficiency. Homology clustering resolved these proteins into distinct groups, for which we performed comprehensive PAM profiling and evaluated editing efficiency in eukaryotic cells. This structure-guided discovery revealed a previously undiscovered landscape of compact nuclease subtypes that exhibit extensive protospacer-adjacent motif (PAM) diversity, expanding the targeting potential of compact editors. Comparative analysis across the novel RNA-guided nuclease families demonstrates that compact systems are not intrinsically limited to highly constrained PAMs but instead have a broad and previously unknown breadth of genome targeting capabilities, comparable to that of Cas9 and far exceeding common transposon- derived systems. Additionally, this search revealed that a compact transposon-associated motif (TAM) is a prerequisite for the emergence of a CRISPR-Cas system from ancestral transposons, before protein domain expansions increase the target length and specificity constraints. These results enrich the catalog of RNA-guided nuclease architectures and contribute validated compact genome editing tools with broad and diverse PAM recognition, which may have therapeutic applications. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/714800v2_ufig1.gif" ALT="Figure 1"> View larger version (64K): org.highwire.dtl.DTLVardef@19ccdc9org.highwire.dtl.DTLVardef@18a5027org.highwire.dtl.DTLVardef@1945836org.highwire.dtl.DTLVardef@2b5bae_HPS_FORMAT_FIGEXP M_FIG C_FIG

genomics↗

Comprehensive genome editing confers "off-the-shelf" CAR-T cells superior efficacy against solid tumors

Biochemical and immunological negative regulators converge to inhibit tumor-reactive Chimeric Antigen Receptor T (CAR-T) cells, which may explain clinical failures of CAR-T cell therapies against solid tumors. Here, we developed a multifaceted approach to genetically engineer allogeneic ( off -the-shelf) CAR-T cells resistant to both biochemical (adenosine) and immunological (PD-L1 and TGF-{beta}) inhibitory signaling. We multiplexed an adenine base editor with a CRISPR-Cas12b nuclease to manufacture a CAR-T cell product comprising six gene edits to evade allorejection (B2M, CIITA), prevent graft-versus-host disease (CD3E) and resist major biochemical (ADORA2A) and immunological (PDCD1, TGFBR2) immunosuppressive barriers in solid tumors. Combinatorial genetic disruption in CAR-T cells enabled superior anti-tumor efficacy leading to improved tumor elimination and survival in humanized mouse models that recapitulated the suppressive features of a human tumor microenvironment (TME). This novel engineering strategy conferred CAR-T cells resistance to a diverse TME, which may unlock the therapeutic potential of CAR-T cells against solid tumors. One Sentence SummaryMultiplex genome engineered CAR-T cells resistant to allorejection and the convergence of biochemical and immunological negative regulators within the tumor microenvironment exhibit superior efficacy against solid tumors.

cell biology↗